超声检查联合血清CEA、AFP在乳腺癌鉴别诊断中的应用价值

doi:10.3969/j.issn.1671-7171.2024.01.023

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1235 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the clinical diagnostic value of ultrasonography combined with carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in breast cancer. 【Methods】 A total of 90 patients with breast cancer (breast cancer group, n=90) and 87 patients with benign breast nodules (benign breast nodules group, n=87) admitted to our hospital from April 2019 to April 2023 were selected, and 100 healthy female volunteers (control group) were selected in the same period. All subjects were examined by ultrasound and serum CEA and AFP levels. The clinical diagnostic value of ultrasound combined with CEA and AFP in breast cancer was analyzed by receiver operating characteristic (ROC) curve. 【Results】 V_max, RI and PI in breast cancer group were significantly higher than those in the benign breast nodules group and the control group (P<0.05). Serum CEA and AFP levels in the breast cancer group were significantly higher than those in the benign breast nodules group and the control group (P<0.05). Ultrasound combined with CEA and AFP had the highest diagnostic value for breast cancer (AUC=0.930), and the predictive sensitivity was 93.0% and 97.5%, respectively, which were higher than any single detection index (P<0.05). 【Conclusion】 Ultrasonography combined with CEA and AFP has high clinical value in the diagnosis of breast cancer. Compared with single detection, its combined application can significantly improve the diagnostic sensitivity and specificity of breast cancer.

Key words： Sarcoidosis/DI Breast Diseases/DI Breast Neoplasms/DI Ultrasonography Carcinoembryonic Antigen/BL alpha-Fetoproteins/BL

Received: 06 August 2023

PACS:

R737.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TIAN Xiuli
	LI Jinsong

Cite this article:

TIAN Xiuli,LI Jinsong. The Value of Ultrasonography Combined with Serum CEA and AFP Levels in the Differential Diagnosis of Breast Cancer[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(1): 85-87.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.01.023 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I1/85

[1] 陈艳,欧阳新平,何平平. 超声联合CA15-3和CEA检测在乳腺癌诊断中的临床意义[J].中国现代医学杂志,2014,24(23):63-66.
[2] 郑阿梅,王传彬,武林松,等. CDFI联合AFP、HSP90α对乳腺癌分期的诊断[J].现代科学仪器,2022,39(3):111-115.
[3] 李兵,冀建峰,吴志华,等. 彩色多普勒超声联合血清CEA、CA125、TK1、TFF1对乳腺癌的诊断价值研究[J].现代生物医学进展,2023,23(16):3072-3076.
[4] 苏巧霞,刘艳群.超声参数联合血清ProGRP、CEA及SF诊断乳腺癌的临床价值[J].影像研究与医学应用,2023,7(6):63.
[5] 中华医学会外科学分会乳腺外科学组. 早期乳腺癌染料法前哨淋巴结活检专家共识及技术操作指南(2018版)[J].中国实用外科杂志,2018,38(8):855-858.
[6] 徐书星,霍庆赟,杨颖,等.乳腺癌患者血清SF、TFF1、PD-L1水平变化及与传统肿瘤标志物的诊断价值比较[J].山东医药,2020,60(20):64-66.
[7] 吴琳,秦峰.ProGRP联合CEA和CA153在乳腺癌患者血清中的表达及其临床诊断价值[J].检验医学与临床,2021,18(23):3387-3390.
[8] 陈琛,王征,郭满高,等.血清CA153、BXTM及CEA联合检测对乳腺癌的早期诊断价值比较[J].中国实验诊断学,2020,24(12):1978-1981.
[9] 刘怡.血清CEA、TNF-α及sTNFR-P55联合检测用于乳腺癌诊断的敏感度与特异性探讨[J].现代肿瘤医学,2019,27(24):4376-4380.
[10] 陈平,樊卫,刘玲.血清AFP、CEA、CA199联合检测原发性肝癌的灵敏度分析[J].医学临床研究,2020,37(7):1090-1092.
[11] 张丽春.实时灰阶超声造影联合血清CEA、CA199水平检测评估高侵袭性乳腺癌新辅助化疗效果的临床价值[J].中国医学创新,2018,15(14):83-87.
[12] 冯岚,景香香,陶阳,等.超声弹性成像联合检测CEA与CA15-3在乳腺癌诊断中的价值分析[J].重庆医学,2018,47(26):3414-3417.
[13] 刘新唐,李玉柱,张海军,等.三维超声与MRI联合血清CA15-3、CEA诊断老年乳腺癌[J].现代肿瘤医学,2018,26(21):3448-3451.